uniQure Inc.: uniQure Announces Enrollment of Next Two Patients in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease,

LEXINGTON, Mass. and AMSTERDAM, Oct. 13, 2020. The ongoing patient enrollment follows a meeting last month of the trial’s independent Data Safety Monitoring Board (DSMB) to review 90-day follow-up dat …, LEXINGTON, Mass. and AMSTERDAM, Oct. 13, 2020. The ongoing patient enrollment follows a meeting last month of the trial’s independent Data Safety Monitoring Board (DSMB) to review 90-day follow-up dat …, Read More